PLOZASIRAN
UNII XG9ARL6P25

Substance Identification & Data

This profile provides standardized clinical and technical data for Plozasiran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XG9ARL6P25.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2379776-40-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XG9ARL6P25

CAS Registry Number

2379776-40-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PLOZASIRAN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

XG9ARL6P25

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C203193

National Cancer Institute reference terminology for clinical and research data.

INN ID

13041

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-219

Identifier assigned by the United States Adopted Names Council.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Plozasiran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PLOZASIRAN

Common Names & Synonyms

PLOZASIRAN [INN]

PLOZASIRAN [USAN]

PLOZASIRAN [WHO-DD]

Systematic Nomenclature

RNA, ((1'-DE(6-AMINO-9H-PURIN-9-YL))DA-(5'->5')-SP-AM-CM-GM-GM-GM-AM-CM-AM-(2'-DEOXY-2'-FLUORO)G-(2'-DEOXY-2'-FLUORO)U-(2'-DEOXY-2'-FLUORO)A-UM-UM-CM-UM-CM-AM-GM-UM-IM-AM-(3'->3')-SP-(1'-DE(6-AMINO-9H-PURIN-9-YL))DA), 3'-(O-(CIS-4-((3S,8S)-17-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)-3,8-BIS(((2-(2-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)ETHOXY)ETHYL)AMINO)CARBONYL)-1,6,11-TRIOXO-15-OXA-2,7,12-TRIAZAHEPTADEC-1-YL)CYCLOHEXYL) HYDROGEN PHOSPHOROTHIOATE), COMPLEX WITH RNA (UM-SP-(2'-DEOXY-2'-FLUORO)C-SP-AM-SP-(2'-DEOXY-2'-FLUORO)C-UM-(2'-DEOXY-2'-FLUORO)G-AM-GM-AM-AM-UM-(2'-DEOXY-2'-FLUORO)A-CM-(2'-DEOXY-2'-FLUORO)U-GM-(2'-DEOXY-2'-FLUORO)U-CM-(2'-DEOXY-2'-FLUORO)C-CM-(2'-DEOXY-2'-FLUORO)G-SP-UM) (1:1)

SYS